Umpang, Daylyn .

HRN: 17-70-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
CEFUROXIME 500MG (TAB)
04/10/2024
04/17/2024
PO
500
2x
2nd RMLE NSVD, ER Delivery
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: